Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Fuji Pharma Co Ltd (4554)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,425.0 -9.0    -0.63%
20:58:25 - Delayed Data. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3816200004 
  • Volume: 38,800
  • Bid/Ask: 1,425.0 / 1,426.0
  • Day's Range: 1,415.0 - 1,434.0
Fuji Pharma Co Ltd 1,425.0 -9.0 -0.63%

4554 Balance Sheet

 
Featured here, the Balance Sheet for Fuji Pharma Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 39793 40400 39114 38297
Cash and Short Term Investments 1375 2161 2324 3975
Cash - - - -
Cash & Equivalents 1375 2161 2324 3975
Short Term Investments - - - -
Total Receivables, Net 16420 16746 16520 14997
Accounts Receivables - Trade, Net 16357 16737 16304 14585
Total Inventory 20850 20546 19371 18524
Prepaid Expenses - - - -
Other Current Assets, Total 1148 947 899 801
Total Assets 85006 84583 85332 84393
Property/Plant/Equipment, Total - Net 21093 21182 20547 19820
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 251 332 412 492
Intangibles, Net 10546 10001 10081 9493
Long Term Investments 12719 11348 14702 16137
Note Receivable - Long Term 63 9 216 412
Other Long Term Assets, Total 1 2 1 1
Other Assets, Total 6181 6065 4225 4481
Total Current Liabilities 32133 27710 29771 28844
Accounts Payable 4961 6775 5672 7108
Payable/Accrued - - - -
Accrued Expenses 526 264 883 474
Notes Payable/Short Term Debt 11800 11300 11300 11300
Current Port. of LT Debt/Capital Leases 9112 3647 5724 5943
Other Current liabilities, Total 5734 5724 6192 4019
Total Liabilities 40941 42602 44156 43951
Total Long Term Debt 6394 12423 11924 12439
Long Term Debt 2083 7983 8683 9083
Capital Lease Obligations 4311 4440 3241 3356
Deferred Income Tax - - - 215
Minority Interest 3 2 2 2
Other Liabilities, Total -9389 -27916 -31334 -31952
Total Equity 44065 41981 41176 40442
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 3799 3799 3799 3799
Additional Paid-In Capital 4409 4409 4409 4409
Retained Earnings (Accumulated Deficit) 32866 31348 29082 27629
Treasury Stock - Common -553 -554 -567 -567
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 3544 2979 4453 5172
Total Liabilities & Shareholders' Equity 85006 84583 85332 84393
Total Common Shares Outstanding 24.31 24.31 24.3 24.3
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4554 Comments

Write your thoughts about Fuji Pharma Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email